GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
1-Year Return
49.13%
This Quarter Return
+7.52%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$357M
AUM Growth
-$45.9M
(-11%)
Cap. Flow
+$1.9M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
48.05%
Holding
58
New
14
Increased
10
Reduced
11
Closed
8
Top Buys
| 1 |
Kura Oncology
KURA
|
$7.77M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$6.63M |
| 3 |
Celldex Therapeutics
CLDX
|
$5.15M |
| 4 |
ESSA Pharma
EPIX
|
$5.08M |
| 5 |
Gyre Therapeutics
GYRE
|
$5.04M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$12.9M |
| 2 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$9.24M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$8.51M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$8.19M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$7.76M |
Sector Composition
| 1 | Healthcare | 92.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Moderna
MRNA
$9.45B
| – | – |
0
| – | – |
|
52
Invesco QQQ Trust
QQQ
$368B
| – | – |
0
| – | – |
|
53
Sarepta Therapeutics
SRPT
$1.93B
| – | – |
-40,000
| Closed | -$6.82M |
|
54
Tempest Therapeutics
TPST
$44.5M
| – | – |
-4,744
| Closed | -$1.98M |
|
|
55
Travere Therapeutics
TVTX
$1.89B
| – | – |
-475,000
| Closed | -$12.9M |
|
56
Wave Life Sciences
WVE
$1.3B
| – | – |
-200,000
| Closed | -$1.57M |
|
|
SURF
57
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| – | – |
-1,000,000
| Closed | -$9.24M |
|
|
FPRX
58
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-500,000
| Closed | -$8.51M |
|